Madeline Li, MD, PhD

Dr. Madeline Li is a clinician-scientist in the Department of Supportive Care, Princess Margaret Cancer Centre. She completed a MD/PhD degree, with graduate studies in molecular genetics from the Department of Medical Biophysics, Ontario Cancer Institute, followed by a psychiatry residency at the University of Toronto and a fellowship in psychiatric oncology and psychoneuroimmunology at the Princess Margaret Cancer Centre.
In addition to clinical practice in cancer psychiatry, Dr. Li conducts multi-disciplinary research in the areas of psychoneuroimmunology, genetics and psychosocial oncology. She is developing a research program exploring the biological contributions to psychological distress in cancer patients. This includes establishing connections between basic laboratory sciences and psychosocial research departments and advocacy to de-stigmatize and promote psycho-education about psychiatric illness in medical illness.
Current research projects involve characterization of cytokine profiles and genetic vulnerability as contributors to depression in cancer patients, and studies exploring the roles of psychological, endocrine, immunologic, and nervous system biomarkers as mediators of non-specific cancer symptoms and symptom clusters, such as pain, depression, fatigue, and insomnia.
Her psychosocial research includes educational strategies on clinical management of depression and anxiety in cancer patients, in addition to screening for emotional distress. She is the developer and physician lead of the Distress Assessment and Response Tool (DART) program at the Princess Margaret, and a co-lead on the Improving Patient Experience and Health Outcomes Collaborative with Cancer Care Ontario.
Aust N Z J Psychiatry. 2019 Nov 21;:4867419888576
Rosenblat JD, Kurdyak P, Cosci F, Berk M, Maes M, Brunoni AR, Li M, Rodin G, McIntyre RS, Carvalho AF
J Geriatr Oncol. 2019 May 09;:
Alibhai SMH, Breunis H, Matelski J, Timilshina N, Kundra A, Lee CH, Li M
J Clin Psychiatry. 2019 Apr 16;80(3):
Rosenblat JD, Carvalho AF, Li M, Lee Y, Subramanieapillai M, McIntyre RS
CMAJ. 2018 02 12;190(6):E169-E170
Li M, Kain D
Qual Life Res. 2018 Nov 22;:
Tang E, Ekundayo O, Peipert JD, Edwards N, Bansal A, Richardson C, Bartlett SJ, Howell D, Li M, Cella D, Novak M, Mucsi I
Psychosomatics. 2018 Oct 10;:
El-Majzoub S, Mucsi I, Li M, Moussaoui G, Lipman ML, Looper KJ, Novak M, Rej S
Support Care Cancer. 2018 Oct 30;:
Li M, Sanders C, Lee CH, Gascon B, Macedo A, Molloy S, Laframboise S, Leung YW
Gen Hosp Psychiatry. 2018 Aug 31;55:15-19
Stewart DE, Rodin G, Li M
Psychooncology. 2018 Aug 13;:
Sawka AM, Watt S, Rodin G, Ezzat S, Howell D, Tsang RW, Brierley JD, Krzyzanowska MK, Goldstein D, Li M
Support Care Cancer. 2018 Jul 08;:
Hall E, Tam E, Liang M, Zhang Q, Liu L, Wong L, Sarabia S, Yeung S, Gill G, Eng L, Perez-Cosio A, Brown MC, Xu W, Li M, Mittmann N, Jones J, Howell D, Liu G


Assistant Professor, Department of Psychiatry, University of Toronto
Scientist, Behavioural Sciences and Health Research, University Health Network
Committee Member, Psychosocial Oncology Program, Cancer Care Ontario